Welcome to the e-CCO Library!

OP08 Inflammatory bowel disease and risk of small bowel cancer: A binational population-based cohort study from Denmark and Sweden
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J. Axelrad1, O. Olen2, M. Sachs2, R. Erichsen3, L. Pedersen3, J. Halfvarson4, J. Askling2, A. Ekbom2, H.T. Sørensen3, J. Ludvigsson5

Created: Thursday, 30 January 2020, 10:12 AM
OP08: Automatic detection of enteric ulcers and erosions in capsule endoscopy using a convolutional neural network
Year: 2021
Source: ECCO'21 Virtual
Authors: SaraivaJr., M.(1);Afonso, J.(1);Ribeiro, T.(1);Cardoso, H.(1);Ferreira, J.(2);Andrade, P.(1);Jorge, R.(2);Lopes, S.(1);Macedo, G.(1)
Created: Wednesday, 2 June 2021, 4:12 PM
OP08: Long-term efficacy and pharmacodynamics of the anti-mucosal addressin cell adhesion molecule-1 (MAdCAM-1) monoclonal antibody SHP647 in Crohn’s disease: the OPERA II study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

G. D’Haens*1, W. Reinisch2, S. D. Lee3, D. Tarabar4, E. Louis5, M. Kłopocka6, J. Klaus7, S. Schreiber8, D. I. Park9, X. Hébuterne10, K. J. Gorelick11, S. W. Martin12, A. Banerjee12, P. Nagy13, Y. Wang14, F. Cataldi14, W. J. Sandborn15

Created: Friday, 22 February 2019, 9:41 AM
OP08: Mucosal healing with vedolizumab in inflammatory bowel disease patients with chronic pouchitis: Evidence from EARNEST, a randomized, double-blind, placebo-controlled trial
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Jairath, V.(1,2)*;Feagan, B.G.(2);Silverberg, M.S.(3);Danese, S.(4);Gionchetti, P.(5);Löwenberg, M.(6);Bressler, B.(7);Ferrante, M.(8);Hart, A.(9);Lindner, D.(10);Escher, A.(10);Jones, S.(10);Shen, B.(11);Travis, S.(12);
Created: Friday, 14 July 2023, 10:43 AM
OP08: The effects of maintenance therapy with upadacitinib on abdominal pain, bowel urgency, and fatigue in patients with moderately to severely active Ulcerative Colitis: Phase 3 U-ACHIEVE maintenance results
Year: 2022
Source: ECCO'22
Authors: Danese, S.(1);Tran, J.(2);D'Haens, G.(3);Rubin, D.T.(4);Aoyama, N.(5);Zhou, W.(2);James, B.(2);Yao, X.(2);SanchezGonzalez, Y.(2);Panaccione, R.(6);
Created: Friday, 11 February 2022, 3:52 PM
OP09 Immunomodulatory mechanisms of faecal microbiota transplantation are associated with clinical response in ulcerative colitis: early results from STOP-Colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M.N. Quraishi1,2, Y.H. Oo3, A. Beggs4, D. Withers3, A. Acharjee4,5, N. Sharma1,2, S. Manzoor1, A.L. Hart6, D.R. Gaya7, N.J. Loman8, P.M. Hawkey1, K. Gerasimidis9, R. Hansen10, G. Gkoutous4,5,11, T.H. Iqbal1,2

Created: Thursday, 30 January 2020, 10:12 AM
OP09: Histological remission and mucosal healing in a randomised, placebo-controlled, Phase 2 study of etrasimod in patients with moderately to severely active ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

L. Peyrin-Biroulet*1, J. Panés2, M. Chiorean3, J. Zhang4, S. Vermeire5, V. Jairath6, A. Yarur7, C. Cabell4, S. Naik4, W. J. Sandborn8

Created: Friday, 22 February 2019, 9:41 AM
OP09: Long-term Colectomy rates of Ulcerative Colitis over 40-year of Different Therapeutic eras – Results from a Western Hungarian Population-based Inception Cohort between 1977–2020
Year: 2023
Source: ECCO’23 Copenhagen
Authors: LakatosPhD, P.L.(1)*;Gonczi, L.(2);Lakatos, L.(3);Golovics, P.A.(4);Pandur, T.(5);David, G.(3);Erdelyi, Z.(3);Szita , I.(3);
Created: Friday, 14 July 2023, 10:43 AM
OP09: Patient reported outcomes reflect histologic disease activity in patients with Ulcerative Colitis: Interim analysis of the APOLLO study
Year: 2021
Source: ECCO'21 Virtual
Authors: Verstockt, B.(1,2,3);Jorissen, C.(1,2);Hoefkens, E.(1);Lembrechts, N.(1);Pouillon, L.(1);Bossuyt, P.(1,2)
Created: Wednesday, 2 June 2021, 4:12 PM
OP09: Proactive Therapeutic Drug Monitoring is superior to standard treatment during maintenance therapy with infliximab; results from a 52-week multicentre randomised trial of 450 patients; the NOR-DRUM B study
Year: 2022
Source: ECCO'22
Authors: Jørgensen, K.K.(1);Syversen, S.W.(2);Goll, G.L.(2); Bjørlykke, K.H.(1,3);Sandanger, Ø.(4);Sexton, J.(2);Brun, M.K.(2,3);Noraberg, G.(5);Ystrøm, C.M.(6); Seeberg, K.A.(7);Blomgren, I.M.(8);Torp, R.(9);Mørk, C.(10);Kvien, T.K.(2,3); Bolstad , N.(4);Haavardsholm, E.A.(2,3);Jahnsen, J.(1,3); The NOR-DRUM study group
Created: Friday, 11 February 2022, 3:52 PM
OP10 IgA coating of intestinal microbiota is associated with inflammatory bowel disease in twin pairs discordant for inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

E. Brand1, Y. Laenen2, F. van Wijk3, M. de Zoete4, B. Oldenburg5, On behalf of the Dutch TWIN-IBD Consortium

Created: Thursday, 30 January 2020, 10:12 AM
OP10: Comparative efficacy of biologics for endoscopic healing of the ileum and colon in Crohn’s Disease
Year: 2022
Source: ECCO'22
Authors: Narula, N.(1);Wong, E.(1);Dulai, P.(2);Marshall, J.(1);Jairath, V.(3);Reinisch, W.(4);
Created: Friday, 11 February 2022, 3:52 PM
OP10: Proctocolectomy with permanent ileostomy is associated with better transplant-free survival in patients with primary sclerosing cholangitis: a retrospective cohort study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Mol, B.(1)*;van Nieuwamerongen, M.(1);van Munster, K.(1);van Munster, S.(1);de Vries, A.(2);van der Meer, A.(2);Goet, J.(2);Weersma, R.(3);Inderson, A.(4);Boonstra, K.(1);van Meer, S.(5);de Boer, Y.(1);Spanier, M.(6);Drenth, J.(7);de Vries, E.(8);Beuers, U.(1);Bogaards, J.(9);Ponsioen, C.(1);
Created: Friday, 14 July 2023, 10:43 AM
OP10: Response to biologics in IBD patients assessed by Computerized image analysis of Probe Based Confocal Laser Endomicroscopy with molecular labeling and gene expression profiling
Year: 2021
Source: ECCO'21 Virtual
Authors: Iacucci, M.(1,2,3);Jeffery, L.(1);Acharjee, A.(4);Nardone, O.M.(1);Smith, S.C.(1);Labarile, N.(1);Zardo, D.(5);Cannatelli, R.(1);Shivaji, U.N.(1);Ungar, B.(1);Buda, A.(6);Grisan, E.(7);Gkoutos, G.(4);Subrata, G.(1,2,3)
Created: Wednesday, 2 June 2021, 4:12 PM
OP10: Systems genomics of ulcerative colitis: combining GWAS and signalling networks for patient stratification and individualised drug targeting in ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. Brooks*1,2, D. Modos3, P. Sudhakar4,5, D. Fazekas4,6, A. Zoufir3, A. Watson1,7, M. Tremelling1, B. Verstockt8, S. Vermeire8, A. Bender3, S. Carding2,7, T. Korcsmaros2,4

Created: Friday, 22 February 2019, 9:41 AM
OP11 Exposure to an inflammatory mix re-induces inflammation in organoids of ulcerative colitis patients, independent of the inflammatory state of the tissue of origin
Year: 2020
Source:

ECCO'20 Vienna

Authors:

K. Arnauts1,2, B. Verstockt1,3, J. Sabino1,3, S. Vermeire1,3, C. Verfaillie2, M. Ferrante1,3

Created: Thursday, 30 January 2020, 10:12 AM
OP11: Expanded genome-wide association study of Inflammatory Bowel Disease identifies 174 novel loci and directly implicates new genes in disease susceptibility
Year: 2022
Source: ECCO'22
Authors: Fachal, L.(1);the International IBD Genetics Consortium, O.B.O.(1);
Created: Friday, 11 February 2022, 3:52 PM
OP11: Ileocecal resection for recently diagnosed ileocecal Crohn's disease is associated with improved long-term outcomes compared to anti-tumor necrosis factor therapy: a population-based study.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Agrawal, M.(1,2)*;Ebert, A.(2);Poulsen, G.(2);Ungaro, R.(1);Faye, A.(3);Jess, T.(2,4);Colombel, J.F.(1);Allin, K.(2,4);
Created: Friday, 14 July 2023, 10:43 AM
OP11: Longitudinal profiling of mucosal immune cell composition using multiplex immunohistochemistry identifies drug- and response-specific patterns in Ulcerative Colitis
Year: 2021
Source: ECCO'21 Virtual
Authors: Volk, V.(1);Aden, K.(2);Tran, F.(2);Mishra, N.(3);Bernardes, J.(3);Röcken, C.(4);Schreiber, S.(2);Feuerhake, F.(1);Rosenstiel, P.(3)
Created: Wednesday, 2 June 2021, 4:12 PM
OP11: Organoids derived from inflamed intestinal biopsies of patients with ulcerative colitis lose their inflammatory phenotype during ex vivo culture
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

K. Arnauts*1,2, B. Verstockt1,3, M. Vancamelbeke1, S. Vermeire1,3, C. Verfaillie2, M. Ferrante1,3

Created: Friday, 22 February 2019, 9:41 AM